Literature DB >> 11683353

Clinical study of adenoid cystic carcinoma of the head and neck.

D Takagi1, S Fukuda, Y Furuta, K Yagi, A Homma, T Nagahashi, Y Inuyama.   

Abstract

OBJECTIVE: We examined prognostic factors and outcome of the primary treatment in patients with adenoid cystic carcinoma (ACC) of the head and neck.
METHODS: Twenty patients with ACC of the head and neck who had been treated in our institution from 1985 to 1998 were enrolled in this study. Disease-specific survival rate was analyzed by the Kaplan-Mejer method, and the log-rank test was applied to compare the survival rates.
RESULTS: The overall 5- and 10-year survival rates determined by Kaplan-Meier analysis were 81 and 57%, respectively. Patients with major salivary gland ACC obtained the best 10-year survival rate (83%), while those with paranasal sinus ACC had the worst survival rate (33%). Predominance of the solid component on pathological examination might indicate a worse prognosis. Our study revealed that postoperative radiotherapy could yield better control of the lesion focus. Chemotherapy failed in some patients and was not dramatically effective by itself.
CONCLUSIONS: The long-term prognosis of ACC was poor. Long-term follow-up is necessary for better prognosis of patients treated with radical treatment regimens.

Entities:  

Mesh:

Year:  2001        PMID: 11683353     DOI: 10.1016/s0385-8146(01)00073-6

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  5 in total

1.  Long-term local control of recurrent adenoid cystic carcinoma in the parotid gland with radiotherapy and intraarterial infusion chemotherapy.

Authors:  Koutarou Terashima; Yoshiyuki Shioyama; Katsumasa Nakamura; Saiji Ohga; Satoshi Nomoto; Toshihiro Yamaguchi; Takashi Toba; Tadamasa Yoshitake; Hidetake Yabuuchi; Torahiko Nakashima; Hiromi Terashima; Hiroshi Honda
Journal:  Radiat Med       Date:  2006-05

2.  Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases.

Authors:  Lester D R Thompson; Carla Penner; Ngoc J Ho; Robert D Foss; Markku Miettinen; Jacqueline A Wieneke; Christopher A Moskaluk; Edward B Stelow
Journal:  Head Neck Pathol       Date:  2013-09-15

3.  Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.

Authors:  Ryuichi Murase; Tomoki Sumida; Akiko Ishikawa; Rumi Murase; Sean D McAllister; Hiroyuki Hamakawa; Pierre-Yves Desprez
Journal:  Int J Otolaryngol       Date:  2011-11-21

4.  Accuracy of methionine-PET in predicting the efficacy of heavy-particle therapy on primary adenoid cystic carcinomas of the head and neck.

Authors:  Sachiko Toubaru; Kyosan Yoshikawa; Seiya Ohashi; Katsuyuki Tanimoto; Azusa Hasegawa; Koji Kawaguchi; Tsuneo Saga; Tadashi Kamada
Journal:  Radiat Oncol       Date:  2013-06-13       Impact factor: 3.481

5.  Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells.

Authors:  Tomoki Sumida; Ryuichi Murase; Akiko Onishi-Ishikawa; Sean D McAllister; Hiroyuki Hamakawa; Pierre-Yves Desprez
Journal:  BMC Cancer       Date:  2013-03-22       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.